Patents by Inventor Charles A. Gilson, III

Charles A. Gilson, III has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESSES FOR PREPARING 3-BENZAZEPINES
    Publication number: 20160185729
    Abstract: The present invention provides processes and intermediates for the preparation of 3-benzazepines and salts thereof which can be useful as serotonin (5-HT) receptor agonists for the treatment of, for example, central nervous system disorders such as obesity.
    Type: Application
    Filed: July 27, 2015
    Publication date: June 30, 2016
    Inventors: Beverly L. Wolgast, Charles A. Gilson, III, Shelley Aytes, Scott A. Estrada, Dipanjan Sengupta, Brian Smith, Max Rey, Ulrich Weigl
  • Processes for preparing 3-benzazepines
    Patent number: 9102627
    Abstract: The present invention provides processes and intermediates for the preparation of 3-benzazepines and salts thereof which can be useful as serotonin (5-HT) receptor agonists for the treatment of, for example, central nervous system disorders such as obesity.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: August 11, 2015
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Beverly L. Wolgast, Charles A. Gilson, III, Shelley Aytes, Scott A. Estrada, Dipanjan Sengupta, Brian Smith, Max Rey, Ulrich Weigl, Heidedore Jlsabeth Rey-Papina
  • Processes for preparing 3-benzazepines
    Patent number: 8946207
    Abstract: The present invention provides processes and intermediates for the preparation of 3-benzazepines and salts thereof which can be useful as serotonin (5-HT) receptor agonists for the treatment of, for example, central nervous system disorders such as obesity.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: February 3, 2015
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Beverly L. Wolgast, Charles A. Gilson, III, Shelley Aytes, Scott A. Estrada, Dipanjan Sengupta, Brian Smith, Ulrich Weigl, Heidedore Jlsabeth Rey-Papina
  • PROCESSES FOR PREPARING 3-BENZAZEPINES
    Publication number: 20130178620
    Abstract: The present invention provides processes and intermediates for the preparation of 3-benzazepines and salts thereof which can be useful as serotonin (5-HT) receptor agonists for the treatment of, for example, central nervous system disorders such as obesity.
    Type: Application
    Filed: September 14, 2012
    Publication date: July 11, 2013
    Inventors: Beverly L. Wolgast, CHARLES A. GILSON, III, SHELLEY AYTES, SCOTT A. ESTRADA, DIPANJAN SENGUPTA, BRIAN SMITH, MAX REY, ULRICH WEIGL, HEIDEDORE JLSABETH REY-PAPINA
  • BENZAZEPINE DERIVATIVES USEFUL FOR TREATMENT OF 5HT2C RECEPTOR ASSOCIATED DISEASES
    Publication number: 20130172322
    Abstract: The present invention relates to certain 1-substituted-2,3,4,5-tetrahydro-3-benzazepine derivatives of Formula (I), that are modulators of the 5HT2C receptor. Accordingly, compounds of the present invention are useful for the prophylaxis or treatment of 5HT2C receptor associated diseases, conditions or disorders, such as, obesity and related disorders.
    Type: Application
    Filed: September 14, 2012
    Publication date: July 4, 2013
    Inventors: Smith Brian, Charles A. Gilson, III, Jeffrey Schultz, Jeffrey Smith
  • PROCESSES FOR PREPARING 3-BENZAZEPINES
    Publication number: 20130165648
    Abstract: The present invention provides processes and intermediates for the preparation of 3-benzazepines and salts thereof which can be useful as serotonin (5-HT) receptor agonists for the treatment of, for example, central nervous system disorders such as obesity.
    Type: Application
    Filed: September 14, 2012
    Publication date: June 27, 2013
    Inventors: Beverly L. Wolgast, Charles A. Gilson, III, Shelley Aytes, Scott A. Estrada, Dipanjan Sengupta, Brian Smith, Max Rey, Ulrich Weigl, Heidedore Jlsabeth Rey-Papina
  • Benzazepine derivatives and methods of prophylaxis or treatment of 5HT2C receptor associated diseases
    Patent number: 8404675
    Abstract: The present invention relates to certain 1-substituted-2,3,4,5-tetrahydro-3-benzazepine derivatives of Formula (I), that are modulators of the 5HT2C receptor. Accordingly, compounds of the present invention are useful for the prophylaxis or treatment of 5HT2C receptor associated diseases, conditions or disorders, such as, obesity and related disorders.
    Type: Grant
    Filed: March 22, 2010
    Date of Patent: March 26, 2013
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Brian Smith, Charles A. Gilson, III, Jeffrey Schultz, Jeffrey Smith
  • Processes for preparing 3-benzazepines
    Patent number: 8367657
    Abstract: The present invention provides processes and intermediates for the preparation of 3-benzazepines and salts thereof which can be useful as serotonin (5-HT) receptor agonists for the treatment of, for example, central nervous system disorders such as obesity.
    Type: Grant
    Filed: June 16, 2004
    Date of Patent: February 5, 2013
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Beverly L. Wolgast, Charles A. Gilson, III, Shelley Aytes, Scott A. Estrada, Dipanjan Sengupta, Brian Smith, Ulrich Weigl, Heidedore Jlsabeth Rey-Papina
  • BENZAZEPINE DERIVATIVES AND METHODS OF PROPHYLAXIS OR TREATMENT OF 5HT2C RECEPTOR ASSOCIATED DISEASES
    Publication number: 20100173894
    Abstract: The present invention relates to certain 1-substituted-2,3,4,5-tetrahydro-3-benzazepine derivatives of Formula (I), that are modulators of the 5HT2C receptor. Accordingly, compounds of the present invention are useful for the prophylaxis or treatment of 5HT2C receptor associated diseases, conditions or disorders, such as, obesity and related disorders.
    Type: Application
    Filed: March 22, 2010
    Publication date: July 8, 2010
    Inventors: Smith Brian, Charles A. Gilson, III, Jeffrey Schultz, Jeffrey Smith
  • Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
    Patent number: 7704993
    Abstract: The present invention relates to certain 1-substituted-2,3,4,5-tetrahydro-3-benzazepine derivatives of Formula (I), that are modulators of the 5HT2C receptor. Accordingly, compounds of the present invention are useful for the prophylaxis or treatment of 5HT2C receptor associated diseases, conditions or disorders, such as, obesity and related disorders.
    Type: Grant
    Filed: June 16, 2004
    Date of Patent: April 27, 2010
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Brian Smith, Charles A. Gilson, III, Jeffrey Schultz, Jeffrey Smith
  • Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2c Receptor Associated Diseases
    Publication number: 20080009478
    Abstract: The present invention relates to substituted-2,3,4,5-tetrahydro-3-benzazepine derivatives that are modulators of the 5HT2C receptor. Accordingly, compounds of the present invention are useful for the prophylaxis or treatment of 5HT2C receptor associated diseases, conditions or disorders, such as, obesity and related disorders.
    Type: Application
    Filed: October 21, 2004
    Publication date: January 10, 2008
    Applicant: Arena Pharmaceuticals, Inc.
    Inventors: Brian Smith, Charles A. Gilson III, Jeffrey A. Schultz, Scott A. Estrada
  • Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2C Receptor Associated Diseases
    Publication number: 20070275949
    Abstract: The present invention relates to substituted-2,3,4,5-tetrahydro-3-benzazepine derivatives that are modulators of the 5HT2C receptor. Accordingly, compounds of the present invention are useful for the prophylaxis treatment of 5HT2C receptor associated diseases, conditions or disorders, such as, obesity and related disorders.
    Type: Application
    Filed: October 21, 2004
    Publication date: November 29, 2007
    Applicant: Arena Pharmaceuticals, Inc.
    Inventors: Brian Smith, Jeffrey Schultz, Charles Gilson III, Scott Estrada